You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
騰盛博藥-B(02137.HK):在美國肝病研究協會年會上分享了三張壁報
格隆匯 11-14 06:33

格隆匯11月14日丨騰盛博藥-B(02137.HK)發佈公吿,公司在馬薩諸塞州波士頓舉行的美國肝病研究協會年會上分享了三張壁報,其中兩張壁報為最新突破壁報,提供了慢性乙型肝炎(“CHB”)臨牀項目中的兩項處於2期研發階段的產品BRII-179 (VBI-2601)和BRII-835 (VIR2218)的最新數據。

公司首席醫學官David Margolis博士表示:“我們很高興能在肝病年會上分享這些數據。這些數據證實我們乙型肝炎病毒(“HBV”)管線組合的多功能性,並展示了我們在尋找HBV功能性治癒方法過程中的重要洞見。乙肝表面抗原(“HBsAg”)清除與抗體應答之間的重要聯繫,為進一步提高功能性治癒率和識別最有可能對治癒性療法產生應答的患者指明瞭方向。我們的目標是在儘可能廣泛的人羣中為合適的患者開發適當的治療方案,同時讓患者避免選擇昂貴或耐受性較差且不會給他們帶來獲益的治療選擇。”

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account